These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25299082)

  • 1. Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma.
    Deng X; Liu P; Zhao Y; Wang Q
    Genet Mol Res; 2014 Sep; 13(3):7686-97. PubMed ID: 25299082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in colorectal cancer.
    Kim KS; Kim JT; Lee SJ; Kang MA; Choe IS; Kang YH; Kim SY; Yeom YI; Lee YH; Kim JH; Kim KH; Kim CN; Kim JW; Nam MS; Lee HG
    Clin Chim Acta; 2013 Jan; 415():12-9. PubMed ID: 22975528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CEACAM6 promotes tumor migration, invasion, and metastasis in gastric cancer.
    Zhang Y; Zang M; Li J; Ji J; Zhang J; Liu X; Qu Y; Su L; Li C; Yu Y; Zhu Z; Liu B; Yan M
    Acta Biochim Biophys Sin (Shanghai); 2014 Apr; 46(4):283-90. PubMed ID: 24492534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased expression of RASSF6 is a novel independent prognostic marker of a worse outcome in gastric cancer patients after curative surgery.
    Wen Y; Wang Q; Zhou C; Yan D; Qiu G; Yang C; Tang H; Peng Z
    Ann Surg Oncol; 2011 Dec; 18(13):3858-67. PubMed ID: 21442347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CEACAM6 promotes tumor angiogenesis and vasculogenic mimicry in gastric cancer via FAK signaling.
    Zang M; Zhang Y; Zhang B; Hu L; Li J; Fan Z; Wang H; Su L; Zhu Z; Li C; Yan C; Gu Q; Liu B; Yan M
    Biochim Biophys Acta; 2015 May; 1852(5):1020-8. PubMed ID: 25703140
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CEACAM5 has different expression patterns in gastric non-neoplastic and neoplastic lesions and cytoplasmic staining is a marker for evaluation of tumor progression in gastric adenocarcinoma.
    Liu JN; Wang HB; Zhou CC; Hu SY
    Pathol Res Pract; 2014 Oct; 210(10):686-93. PubMed ID: 25042385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression patterns of CEACAM5 and CEACAM6 in primary and metastatic cancers.
    Blumenthal RD; Leon E; Hansen HJ; Goldenberg DM
    BMC Cancer; 2007 Jan; 7():2. PubMed ID: 17201906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of matrix metalloproteinase 11 in human gastric carcinoma and its clinicopathologic significance.
    Zhao ZS; Chu YQ; Ye ZY; Wang YY; Tao HQ
    Hum Pathol; 2010 May; 41(5):686-96. PubMed ID: 20060156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dual role of carcinoembryonic antigen-related cell adhesion molecule 6 expression in predicting the overall survival of gastric cancer patients.
    Zang M; Hu L; Cao S; Fan Z; Pang L; Li J; Su L; Li C; Liu W; Gu Q; Zhu Z; Yan M; Liu B
    Sci Rep; 2017 Sep; 7(1):10773. PubMed ID: 28883649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sineoculis homeobox homolog 1 protein as an independent biomarker for gastric adenocarcinoma.
    Lv H; Cui A; Sun F; Zhang Y; Li Y; Li L; Lin Z
    Exp Mol Pathol; 2014 Aug; 97(1):74-80. PubMed ID: 24866365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression and clinical significance of carcinoembryonic antigen-related cell adhesion molecule 6 in breast cancers.
    Tsang JY; Kwok YK; Chan KW; Ni YB; Chow WN; Lau KF; Shao MM; Chan SK; Tan PH; Tse GM
    Breast Cancer Res Treat; 2013 Nov; 142(2):311-22. PubMed ID: 24186057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of minichromosome maintenance 2 predicts poor prognosis in patients with gastric cancer.
    Yang C; Wen Y; Li H; Zhang D; Zhang N; Shi X; Jiang B; Ma X; Yang P; Tang H; Peng Z; Yang Y
    Oncol Rep; 2012 Jan; 27(1):135-42. PubMed ID: 21947329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Intraperitoneal-free
    Kaku H; Aoyagi K; Sudo T; Tanaka Y; Minami T; Isobe T; Kizaki J; Umetani Y; Murakami N; Fujita F; Akagi Y
    Anticancer Res; 2022 Aug; 42(8):4003-4010. PubMed ID: 35896219
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered expression of estrogen receptor alpha and beta in advanced gastric adenocarcinoma: correlation with prothymosin alpha and clinicopathological parameters.
    Wang M; Pan JY; Song GR; Chen HB; An LJ; Qu SX
    Eur J Surg Oncol; 2007 Mar; 33(2):195-201. PubMed ID: 17046193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
    Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
    Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated plasma osteopontin associated with gastric cancer development, invasion and survival.
    Wu CY; Wu MS; Chiang EP; Wu CC; Chen YJ; Chen CJ; Chi NH; Chen GH; Lin JT
    Gut; 2007 Jun; 56(6):782-9. PubMed ID: 17148500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vimentin expression is associated with decreased survival in gastric cancer.
    Otsuki S; Inokuchi M; Enjoji M; Ishikawa T; Takagi Y; Kato K; Yamada H; Kojima K; Sugihara K
    Oncol Rep; 2011 May; 25(5):1235-42. PubMed ID: 21327330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carcinoembryonic antigen cell adhesion molecule 6 (CEACAM6) in Pancreatic Ductal Adenocarcinoma (PDA): An integrative analysis of a novel therapeutic target.
    Pandey R; Zhou M; Islam S; Chen B; Barker NK; Langlais P; Srivastava A; Luo M; Cooke LS; Weterings E; Mahadevan D
    Sci Rep; 2019 Dec; 9(1):18347. PubMed ID: 31797958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of CEACAM6 promotes insulin-like growth factor I-induced pancreatic adenocarcinoma cellular invasiveness.
    Duxbury MS; Ito H; Benoit E; Zinner MJ; Ashley SW; Whang EE
    Oncogene; 2004 Jul; 23(34):5834-42. PubMed ID: 15208677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.